Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2545)	1/12/2001 10:10:21 AM
From: Biomaven	Read Replies (6) \| Respond to of 52153

What do people think about my creating some disease-specific threads? I'm thinking in particular about diseases where there are many different competitors chasing one indication - psoriasis would be the paradigmatic example. Lots of interesting trials and new research (like today's IL-20 announcement from ZymoGenetics). Right now all the info is generally scattered among many different threads. (The biotech cancer thread is an existing exception). There's a significant valuation issue here - e.g., in psoriasis, there is a huge unmet need, but there aren't going to be 20 winners - more like three or four winners and a whole bunch of losers. Possible ideas: - one thread for each major disease - a thread combining a bunch of diseases - just keep it all here on the valuation thread, or use the biotech news thread or some other existing thread I've forgotten about. I'm sensitive to the "yet another thread" problem, so I'm somewhat cautious on the whole issue. Mostly inactive threads are a pain to follow, which argues against too narrow a focus in any one thread. However, from a resource point of view things are easier if you have a fairly narrow focus. Comments? Is this a useful idea at all? If so, suggestions for appropriate indications that make sense to cover? Peter